EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY-SA 4.0

Serum High-Sensitivity C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome: A Case-Control Study

Naga Tejaswini Malluru, Rajni Agarwal, Mridula Sharma

International Journal of Medical Research · 01.01.2026 · 14 (01) · 1-7

DOI: 10.55489/ijmr.1401202690 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift International Journal of Medical Research, online erschienen am 01.01.2026. Verfasst von Naga Tejaswini Malluru und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polycystic Ovary Syndrome is a prevalent endocrine disorder marked by reproductive and metabolic disturbances, often accompanied by chronic low-grade inflammation. High-sensitivity C-reactive protein (hs-CRP) has gained attention as a potential marker reflecting this inflammatory burden and its metabolic consequences. This study aimed to assess the diagnostic value of hs-CRP and its association with clinical features in women with PCOS.

Method

A case-control study was done over one year at a tertiary care center, including 42 women diagnosed with PCOS based on Rotterdam criteria and 83 age-matched healthy controls. Demographic, anthropometric, clinical, and biochemical parameters were recorded. hs-CRP levels were estimated using standardized laboratory methods. Statistical analysis included independent t-tests, chi-square tests, and ROC curve analysis, with p < 0.05 considered significant.

Result

PCOS patients had significantly higher hs-CRP levels (3.9 ± 3.6 mg/L) than controls (1.0 ± 1.1 mg/L; p < 0.001). ROC analysis showed good diagnostic performance (AUC 0.827). A cutoff of 1.17 mg/L showed 85.7% sensitivity and 68.7% specificity. Dysmenorrhea showed a significant association with higher hs-CRP categories, while other symptoms showed non-significant trends toward elevated levels. Conclusion: hs-CRP is a valuable marker for identifying inflammatory and metabolic risk in PCOS and may support early risk stratification.

Zitieren

APA

Malluru, N. T., Agarwal, R., & Sharma, M. (2026). Serum High-Sensitivity C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome: A Case-Control Study. International Journal of Medical Research, 14(01), 1-7. https://doi.org/10.55489/ijmr.1401202690

Vancouver

Malluru NT, Agarwal R, Sharma M. Serum High-Sensitivity C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome: A Case-Control Study. International Journal of Medical Research. 2026;14(01):1-7. doi:10.55489/ijmr.1401202690

BibTeX
@article{Malluru2026,
  author = {Malluru, Naga Tejaswini and Agarwal, Rajni and Sharma, Mridula},
  title = {Serum High-Sensitivity C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome: A Case-Control Study},
  journal = {International Journal of Medical Research},
  year = {2026},
  volume = {14},
  number = {01},
  pages = {1--7},
  doi = {10.55489/ijmr.1401202690}
}
Kostenlos starten →